Replies to post #351510 on Bioelectronics Corp (BIEL)

[G-star]

Kelly Whelan became CEO of BioElectronics Corporation on November 15, 2019.

2017: First OTC clearance (limited indications)
2019: RecoveryRx clearance.This was on July 1, 2019.
2020: Major expanded clearance (all musculoskeletal pain)This was on Feb 3, 2020.

[gimmee greenbacks]

We’re both right..

Biel had one clearance for the eye, plantar fasciitis and knee arthritis RecoveryRX and Allay for menstrual pain in July 2019 under Amy’s watch.

And passed in. October 2019

https://www.newmediawire.com/news/bioelectronics-founder-and-ceo-andrew-j-whelan-has-died-suddenly-4831179

Biel received FDA clearance for musculoskeletal pain in November 2020 under Kellys watch.

https://news.decresearch.com/bioelectronics-announces-new-510k-fda-clearance-actipatch-device


BIEL